Literature DB >> 12421959

CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15.

Ling Ling Ma1, Jason C L Spurrell, Jian Fei Wang, Graham G Neely, Slava Epelman, Alan M Krensky, Christopher H Mody.   

Abstract

Granulysin is located in the acidic granules of cytotoxic T cells. Although the purified protein has antimicrobial activity against a broad spectrum of microbial pathogens, direct evidence for granulysin-mediated cytotoxicity has heretofore been lacking. Studies were performed to examine the regulation and activity of granulysin expressed by CD8 T cells using Cryptococcus neoformans, which is one of the most common opportunistic pathogens of AIDS patients. IL-15-activated CD8 T cells acquired anticryptococcal activity, which correlated with the up-regulation of granulysin. When granules containing granulysin were depleted using SrCl(2,) or when the gene was silenced using 21-nt small interfering RNA duplexes, the antifungal effect of CD8 T cells was abrogated. Concanamycin A and EGTA did not affect the antifungal effect, suggesting that the activity of granulysin was perforin independent. Following stimulation by the C. neoformans mitogen, CD8 T cells expressed granulysin and acquired antifungal activity. This activity required CD4 T cells and was dependent upon accessory cells. Furthermore, IL-15 was both necessary and sufficient for granulysin up-regulation in CD8 T cells. These observations are most consistent with a mechanism whereby C. neoformans mitogen is presented to CD4 T cells, which in turn activate accessory cells. The resultant IL-15 activates CD8 T cells to express granulysin, which is responsible for antifungal activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421959     DOI: 10.4049/jimmunol.169.10.5787

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Streptococcus uberis-specific T cells are present in mammary gland secretions of cows and can be activated to kill S. uberis.

Authors:  Michel Denis; S Jane Lacy-Hulbert; Bryce M Buddle; John H Williamson; D Neil Wedlock
Journal:  Vet Res Commun       Date:  2011-02-01       Impact factor: 2.459

2.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

Review 3.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile.

Authors:  Tanja Breinig; Nicoletta Scheller; Birgit Glombitza; Frank Breinig; Andreas Meyerhans
Journal:  Med Microbiol Immunol       Date:  2011-09-25       Impact factor: 3.402

Review 5.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 6.  Granulysin: killer lymphocyte safeguard against microbes.

Authors:  Farokh Dotiwala; Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2019-05-18       Impact factor: 7.486

Review 7.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

Review 8.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

9.  Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Authors:  Heiko Bruns; Christoph Meinken; Philipp Schauenberg; Georg Härter; Peter Kern; Robert L Modlin; Christian Antoni; Steffen Stenger
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

10.  Comparative antimicrobial activity of granulysin against bacterial biothreat agents.

Authors:  Janice J Endsley; Alfredo G Torres; Christine M Gonzales; Valeri G Kosykh; Vladimir L Motin; Johnny W Peterson; D Mark Estes; Gary R Klimpel
Journal:  Open Microbiol J       Date:  2009-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.